Details for New Drug Application (NDA): 090719
✉ Email this page to a colleague
The generic ingredient in LEVONEST is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 090719
Tradename: | LEVONEST |
Applicant: | Novast Labs Ltd |
Ingredient: | ethinyl estradiol; levonorgestrel |
Patents: | 0 |
Suppliers and Packaging for NDA: 090719
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVONEST | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 090719 | ANDA | Northstar Rx LLC | 16714-340 | 16714-340-01 | 1 BLISTER PACK in 1 PACKET (16714-340-01) / 1 KIT in 1 BLISTER PACK |
LEVONEST | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 090719 | ANDA | Northstar Rx LLC | 16714-340 | 16714-340-02 | 1 BLISTER PACK in 1 CARTON (16714-340-02) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG | ||||
Approval Date: | Dec 29, 2010 | TE: | AB | RLD: | No |
Complete Access Available with Subscription